Fibroscan is a non-invasive diagnostic test used to assess liver health by measuring liver stiffness and detecting fibrosis (scarring) or steatosis (fat accumulation). It uses transient elastography, a specialized ultrasound technology, to evaluate the liver without the need for invasive procedures like a biopsy.
Fibroscan is particularly valuable in managing chronic liver diseases, such as hepatitis B, hepatitis C, fatty liver disease, and alcoholic liver disease. By measuring the degree of liver stiffness, it helps doctors determine the extent of liver damage and the progression of liver fibrosis. This information is critical for evaluating liver function and determining the right treatment approach.
The procedure is quick, painless, and requires no sedation. A probe is placed on the skin over the liver, sending a series of low-frequency waves through the liver tissue. The device measures the speed of the waves as they pass through the liver, with stiffer liver tissue indicating more advanced fibrosis or cirrhosis.
Fibroscan is widely used because it offers a safer and more comfortable alternative to liver biopsy, which involves tissue removal and carries risks such as bleeding or infection. It also provides immediate results, allowing for timely diagnosis and management.
Overall, Fibroscan is an essential tool in liver disease management, offering a reliable, non-invasive way to monitor liver health, assess treatment effectiveness, and make informed decisions about lifestyle changes or medical interventions.
Powered By
